Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant:: characterization of the VanD5 operon

被引:33
作者
Boyd, DA
Kibsey, P
Roscoe, D
Mulvey, MR
机构
[1] Hlth Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada
[2] Victoria Gen Hosp, Victoria, BC, Canada
[3] Vancouver Gen Hosp, Vancouver, BC, Canada
关键词
glycopeptide resistance; van PCR; E; faecium;
D O I
10.1093/jac/dkh391
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To genotypically characterize the vancomycin resistance mechanism of Enterococcus faecium N03-0072, which was negative by PCR for the currently known van genotypes. Methods: PCR was used to amplify the entire vancomycin resistance operon and the complete nucleotide sequence was determined by dideoxy cycle sequencing. Results: Analysis revealed a VanD-type operon with 94% nucleotide identity to the VanD4 operon and 90% nucleotide identity to the VanD1/D3 operons. A set of universal primers was designed in order to identify all current vanD variants by PCR. Conclusions: E. faecium N03-0072 carries a new VanD-type operon, designated VanD5.
引用
收藏
页码:680 / 683
页数:4
相关论文
共 10 条
  • [1] Boyd DA, 2000, J CLIN MICROBIOL, V38, P2392
  • [2] Characterization of the vanD glycopeptide resistance gene cluster from Entercoccus faecium BM4339
    Casadewall, B
    Courvalin, P
    [J]. JOURNAL OF BACTERIOLOGY, 1999, 181 (12) : 3644 - 3648
  • [3] Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil
    Dalla Costa, LM
    Reynolds, PE
    Souza, HAPHM
    Souza, DC
    Palepou, MFI
    Woodford, N
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3444 - 3446
  • [4] VanD-Type vancomycin-resistant Enterococcus faecium 10/96A
    Depardieu, F
    Reynolds, PE
    Courvalin, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 7 - 18
  • [5] Sequencing of the ddl gene and modeling of the mutated D-alanine:D-alanine ligase in glycopeptide-dependent strains of Enterococcus faecium
    Gholizadeh, Y
    Prevost, M
    Van Bambeke, F
    Casadewall, B
    Tulkens, PM
    Courvalin, P
    [J]. PROTEIN SCIENCE, 2001, 10 (04) : 836 - 844
  • [6] MULVEY M, 2003, 43 INT C ANT AG CHEM, P86
  • [7] A cluster of VanD vancomycin-resistant Enterococcus faecium:: Molecular characterization and clinical epidemiology
    Ostrowsky, BE
    Clark, NC
    Thauvin-Eliopoulos, C
    Venkataraman, L
    Samore, MH
    Tenover, FC
    Eliopoulos, GM
    Moellering, RC
    Gold, HS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) : 1177 - 1185
  • [8] Glycopeptide-resistant Enterococcus faecium BM4416 is a VanD-type strain with an impaired D-Alanine:D-Alanine ligase
    Perichon, B
    Casadewall, B
    Reynolds, P
    Courvalin, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (05) : 1346 - 1348
  • [9] VanD-type glycopeptide-resistant Enterococcus faecium BM4339
    Perichon, B
    Reynolds, P
    Courvalin, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2016 - 2018
  • [10] Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci
    Woodford, N
    [J]. MICROBIAL DRUG RESISTANCE, 2001, 7 (03) : 229 - 236